Global Therapeutic Enzyme Drugs Market Insights, Forecast to 2028

Q: Who are the key players in the therapeutic enzyme drugs market?

Some of the key players are Sanofi, BioMarin, AbbVie, Shire Plc, Alexion, Horizon Pharma, Allergan plc, Johnson & Johnson, Recordati Rare Diseases, Pfizer Inc, VIVUS, Digestive Care, Japan, Sanofi S A, Others.

Code: QYRE-Auto-29F2881

Report

March 2022

Pages:108

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Recordati Rare Diseases

Market Analysis and Insights: Global Therapeutic Enzyme Drugs Market

The global Therapeutic Enzyme Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Injectable accounting for % of the Therapeutic Enzyme Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Gaucher Disease segment is altered to an % CAGR throughout this forecast period.

China Therapeutic Enzyme Drugs market size is valued at US$ million in 2021, while the North America and Europe Therapeutic Enzyme Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Therapeutic Enzyme Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Enzyme Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Enzyme Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Enzyme Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Enzyme Drugs market.

Global Therapeutic Enzyme Drugs Scope and Market Size

Therapeutic Enzyme Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Therapeutic Enzyme Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Injectable

Oral

Topical

Segment by Application

Gaucher Disease

MPS Disease

Gastrointestinal Diseases

Others

BY COMPANY

Sanofi

BioMarin

AbbVie

Shire

Alexion

Horizon Pharma

Allergan

Johnson & Johnson

Recordati Rare Diseases

Pfizer

Vivus

Digestive Care

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Recordati Rare Diseases

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Injectable

1.2.3 Oral

1.2.4 Topical

1.3 Market by Application

1.3.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Gaucher Disease

1.3.3 MPS Disease

1.3.4 Gastrointestinal Diseases

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Therapeutic Enzyme Drugs Market Perspective (2017-2028)

2.2 Therapeutic Enzyme Drugs Growth Trends by Region

2.2.1 Therapeutic Enzyme Drugs Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Therapeutic Enzyme Drugs Historic Market Size by Region (2017-2022)

2.2.3 Therapeutic Enzyme Drugs Forecasted Market Size by Region (2023-2028)

2.3 Therapeutic Enzyme Drugs Market Dynamics

2.3.1 Therapeutic Enzyme Drugs Industry Trends

2.3.2 Therapeutic Enzyme Drugs Market Drivers

2.3.3 Therapeutic Enzyme Drugs Market Challenges

2.3.4 Therapeutic Enzyme Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Therapeutic Enzyme Drugs Players by Revenue

3.1.1 Global Top Therapeutic Enzyme Drugs Players by Revenue (2017-2022)

3.1.2 Global Therapeutic Enzyme Drugs Revenue Market Share by Players (2017-2022)

3.2 Global Therapeutic Enzyme Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Therapeutic Enzyme Drugs Revenue

3.4 Global Therapeutic Enzyme Drugs Market Concentration Ratio

3.4.1 Global Therapeutic Enzyme Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Enzyme Drugs Revenue in 2021

3.5 Therapeutic Enzyme Drugs Key Players Head office and Area Served

3.6 Key Players Therapeutic Enzyme Drugs Product Solution and Service

3.7 Date of Enter into Therapeutic Enzyme Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Enzyme Drugs Breakdown Data by Type

4.1 Global Therapeutic Enzyme Drugs Historic Market Size by Type (2017-2022)

4.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2023-2028)

5 Therapeutic Enzyme Drugs Breakdown Data by Application

5.1 Global Therapeutic Enzyme Drugs Historic Market Size by Application (2017-2022)

5.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Therapeutic Enzyme Drugs Market Size (2017-2028)

6.2 North America Therapeutic Enzyme Drugs Market Size by Type

6.2.1 North America Therapeutic Enzyme Drugs Market Size by Type (2017-2022)

6.2.2 North America Therapeutic Enzyme Drugs Market Size by Type (2023-2028)

6.2.3 North America Therapeutic Enzyme Drugs Market Share by Type (2017-2028)

6.3 North America Therapeutic Enzyme Drugs Market Size by Application

6.3.1 North America Therapeutic Enzyme Drugs Market Size by Application (2017-2022)

6.3.2 North America Therapeutic Enzyme Drugs Market Size by Application (2023-2028)

6.3.3 North America Therapeutic Enzyme Drugs Market Share by Application (2017-2028)

6.4 North America Therapeutic Enzyme Drugs Market Size by Country

6.4.1 North America Therapeutic Enzyme Drugs Market Size by Country (2017-2022)

6.4.2 North America Therapeutic Enzyme Drugs Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Therapeutic Enzyme Drugs Market Size (2017-2028)

7.2 Europe Therapeutic Enzyme Drugs Market Size by Type

7.2.1 Europe Therapeutic Enzyme Drugs Market Size by Type (2017-2022)

7.2.2 Europe Therapeutic Enzyme Drugs Market Size by Type (2023-2028)

7.2.3 Europe Therapeutic Enzyme Drugs Market Share by Type (2017-2028)

7.3 Europe Therapeutic Enzyme Drugs Market Size by Application

7.3.1 Europe Therapeutic Enzyme Drugs Market Size by Application (2017-2022)

7.3.2 Europe Therapeutic Enzyme Drugs Market Size by Application (2023-2028)

7.3.3 Europe Therapeutic Enzyme Drugs Market Share by Application (2017-2028)

7.4 Europe Therapeutic Enzyme Drugs Market Size by Country

7.4.1 Europe Therapeutic Enzyme Drugs Market Size by Country (2017-2022)

7.4.2 Europe Therapeutic Enzyme Drugs Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size (2017-2028)

8.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type

8.2.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Therapeutic Enzyme Drugs Market Share by Type (2017-2028)

8.3 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application

8.3.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Therapeutic Enzyme Drugs Market Share by Application (2017-2028)

8.4 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region

8.4.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Therapeutic Enzyme Drugs Market Size (2017-2028)

9.2 Latin America Therapeutic Enzyme Drugs Market Size by Type

9.2.1 Latin America Therapeutic Enzyme Drugs Market Size by Type (2017-2022)

9.2.2 Latin America Therapeutic Enzyme Drugs Market Size by Type (2023-2028)

9.2.3 Latin America Therapeutic Enzyme Drugs Market Share by Type (2017-2028)

9.3 Latin America Therapeutic Enzyme Drugs Market Size by Application

9.3.1 Latin America Therapeutic Enzyme Drugs Market Size by Application (2017-2022)

9.3.2 Latin America Therapeutic Enzyme Drugs Market Size by Application (2023-2028)

9.3.3 Latin America Therapeutic Enzyme Drugs Market Share by Application (2017-2028)

9.4 Latin America Therapeutic Enzyme Drugs Market Size by Country

9.4.1 Latin America Therapeutic Enzyme Drugs Market Size by Country (2017-2022)

9.4.2 Latin America Therapeutic Enzyme Drugs Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size (2017-2028)

10.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type

10.2.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Therapeutic Enzyme Drugs Market Share by Type (2017-2028)

10.3 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application

10.3.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Therapeutic Enzyme Drugs Market Share by Application (2017-2028)

10.4 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country

10.4.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Therapeutic Enzyme Drugs Introduction

11.1.4 Sanofi Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.1.5 Sanofi Recent Developments

11.2 BioMarin

11.2.1 BioMarin Company Details

11.2.2 BioMarin Business Overview

11.2.3 BioMarin Therapeutic Enzyme Drugs Introduction

11.2.4 BioMarin Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.2.5 BioMarin Recent Developments

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Therapeutic Enzyme Drugs Introduction

11.3.4 AbbVie Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.3.5 AbbVie Recent Developments

11.4 Shire

11.4.1 Shire Company Details

11.4.2 Shire Business Overview

11.4.3 Shire Therapeutic Enzyme Drugs Introduction

11.4.4 Shire Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.4.5 Shire Recent Developments

11.5 Alexion

11.5.1 Alexion Company Details

11.5.2 Alexion Business Overview

11.5.3 Alexion Therapeutic Enzyme Drugs Introduction

11.5.4 Alexion Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.5.5 Alexion Recent Developments

11.6 Horizon Pharma

11.6.1 Horizon Pharma Company Details

11.6.2 Horizon Pharma Business Overview

11.6.3 Horizon Pharma Therapeutic Enzyme Drugs Introduction

11.6.4 Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.6.5 Horizon Pharma Recent Developments

11.7 Allergan

11.7.1 Allergan Company Details

11.7.2 Allergan Business Overview

11.7.3 Allergan Therapeutic Enzyme Drugs Introduction

11.7.4 Allergan Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.7.5 Allergan Recent Developments

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Therapeutic Enzyme Drugs Introduction

11.8.4 Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.8.5 Johnson & Johnson Recent Developments

11.9 Recordati Rare Diseases

11.9.1 Recordati Rare Diseases Company Details

11.9.2 Recordati Rare Diseases Business Overview

11.9.3 Recordati Rare Diseases Therapeutic Enzyme Drugs Introduction

11.9.4 Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.9.5 Recordati Rare Diseases Recent Developments

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Therapeutic Enzyme Drugs Introduction

11.10.4 Pfizer Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.10.5 Pfizer Recent Developments

11.11 Vivus

11.11.1 Vivus Company Details

11.11.2 Vivus Business Overview

11.11.3 Vivus Therapeutic Enzyme Drugs Introduction

11.11.4 Vivus Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.11.5 Vivus Recent Developments

11.12 Digestive Care

11.12.1 Digestive Care Company Details

11.12.2 Digestive Care Business Overview

11.12.3 Digestive Care Therapeutic Enzyme Drugs Introduction

11.12.4 Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2017-2022)

11.12.5 Digestive Care Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Recordati Rare Diseases

List of Tables

Table 1. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Injectable

Table 3. Key Players of Oral

Table 4. Key Players of Topical

Table 5. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 6. Global Therapeutic Enzyme Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Therapeutic Enzyme Drugs Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Therapeutic Enzyme Drugs Market Share by Region (2017-2022)

Table 9. Global Therapeutic Enzyme Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Therapeutic Enzyme Drugs Market Share by Region (2023-2028)

Table 11. Therapeutic Enzyme Drugs Market Trends

Table 12. Therapeutic Enzyme Drugs Market Drivers

Table 13. Therapeutic Enzyme Drugs Market Challenges

Table 14. Therapeutic Enzyme Drugs Market Restraints

Table 15. Global Therapeutic Enzyme Drugs Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Therapeutic Enzyme Drugs Revenue Share by Players (2017-2022)

Table 17. Global Top Therapeutic Enzyme Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2021)

Table 18. Ranking of Global Top Therapeutic Enzyme Drugs Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Therapeutic Enzyme Drugs Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Therapeutic Enzyme Drugs Product Solution and Service

Table 22. Date of Enter into Therapeutic Enzyme Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Therapeutic Enzyme Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2017-2022)

Table 26. Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2023-2028)

Table 28. Global Therapeutic Enzyme Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Therapeutic Enzyme Drugs Revenue Share by Application (2017-2022)

Table 30. Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Therapeutic Enzyme Drugs Revenue Share by Application (2023-2028)

Table 32. North America Therapeutic Enzyme Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 33. North America Therapeutic Enzyme Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 34. North America Therapeutic Enzyme Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 35. North America Therapeutic Enzyme Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 36. North America Therapeutic Enzyme Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 37. North America Therapeutic Enzyme Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 38. Europe Therapeutic Enzyme Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 39. Europe Therapeutic Enzyme Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 40. Europe Therapeutic Enzyme Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 41. Europe Therapeutic Enzyme Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 42. Europe Therapeutic Enzyme Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 43. Europe Therapeutic Enzyme Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 44. Asia Pacific Therapeutic Enzyme Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 45. Asia Pacific Therapeutic Enzyme Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 46. Asia Pacific Therapeutic Enzyme Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 47. Asia Pacific Therapeutic Enzyme Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 48. Asia Pacific Therapeutic Enzyme Drugs Market Size by Region (2017-2022) & (US$ Million)

Table 49. Asia Pacific Therapeutic Enzyme Drugs Market Size by Region (2023-2028) & (US$ Million)

Table 50. Latin America Therapeutic Enzyme Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 51. Latin America Therapeutic Enzyme Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 52. Latin America Therapeutic Enzyme Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 53. Latin America Therapeutic Enzyme Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 54. Latin America Therapeutic Enzyme Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 55. Latin America Therapeutic Enzyme Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Therapeutic Enzyme Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Therapeutic Enzyme Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Therapeutic Enzyme Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Therapeutic Enzyme Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Therapeutic Enzyme Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Therapeutic Enzyme Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 62. Sanofi Company Details

Table 63. Sanofi Business Overview

Table 64. Sanofi Therapeutic Enzyme Drugs Product

Table 65. Sanofi Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 66. Sanofi Recent Developments

Table 67. BioMarin Company Details

Table 68. BioMarin Business Overview

Table 69. BioMarin Therapeutic Enzyme Drugs Product

Table 70. BioMarin Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 71. BioMarin Recent Developments

Table 72. AbbVie Company Details

Table 73. AbbVie Business Overview

Table 74. AbbVie Therapeutic Enzyme Drugs Product

Table 75. AbbVie Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 76. AbbVie Recent Developments

Table 77. Shire Company Details

Table 78. Shire Business Overview

Table 79. Shire Therapeutic Enzyme Drugs Product

Table 80. Shire Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 81. Shire Recent Developments

Table 82. Alexion Company Details

Table 83. Alexion Business Overview

Table 84. Alexion Therapeutic Enzyme Drugs Product

Table 85. Alexion Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 86. Alexion Recent Developments

Table 87. Horizon Pharma Company Details

Table 88. Horizon Pharma Business Overview

Table 89. Horizon Pharma Therapeutic Enzyme Drugs Product

Table 90. Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 91. Horizon Pharma Recent Developments

Table 92. Allergan Company Details

Table 93. Allergan Business Overview

Table 94. Allergan Therapeutic Enzyme Drugs Product

Table 95. Allergan Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 96. Allergan Recent Developments

Table 97. Johnson & Johnson Company Details

Table 98. Johnson & Johnson Business Overview

Table 99. Johnson & Johnson Therapeutic Enzyme Drugs Product

Table 100. Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 101. Johnson & Johnson Recent Developments

Table 102. Recordati Rare Diseases Company Details

Table 103. Recordati Rare Diseases Business Overview

Table 104. Recordati Rare Diseases Therapeutic Enzyme Drugs Product

Table 105. Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 106. Recordati Rare Diseases Recent Developments

Table 107. Pfizer Company Details

Table 108. Pfizer Business Overview

Table 109. Pfizer Therapeutic Enzyme Drugs Product

Table 110. Pfizer Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 111. Pfizer Recent Developments

Table 112. Vivus Company Details

Table 113. Vivus Business Overview

Table 114. Vivus Therapeutic Enzyme Drugs Product

Table 115. Vivus Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 116. Vivus Recent Developments

Table 117. Digestive Care Company Details

Table 118. Digestive Care Business Overview

Table 119. Digestive Care Therapeutic Enzyme Drugs Product

Table 120. Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2017-2022) & (US$ Million)

Table 121. Digestive Care Recent Developments

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Therapeutic Enzyme Drugs Market Share by Type: 2021 VS 2028

Figure 2. Injectable Features

Figure 3. Oral Features

Figure 4. Topical Features

Figure 5. Global Therapeutic Enzyme Drugs Market Share by Application: 2021 VS 2028

Figure 6. Gaucher Disease Case Studies

Figure 7. MPS Disease Case Studies

Figure 8. Gastrointestinal Diseases Case Studies

Figure 9. Others Case Studies

Figure 10. Therapeutic Enzyme Drugs Report Years Considered

Figure 11. Global Therapeutic Enzyme Drugs Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global Therapeutic Enzyme Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Therapeutic Enzyme Drugs Market Share by Region: 2021 VS 2028

Figure 14. Global Therapeutic Enzyme Drugs Market Share by Players in 2021

Figure 15. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by Therapeutic Enzyme Drugs Revenue in 2021

Figure 17. North America Therapeutic Enzyme Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America Therapeutic Enzyme Drugs Market Size Market Share by Type (2017-2028)

Figure 19. North America Therapeutic Enzyme Drugs Market Size Market Share by Application (2017-2028)

Figure 20. North America Therapeutic Enzyme Drugs Market Size Share by Country (2017-2028)

Figure 21. United States Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Therapeutic Enzyme Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe Therapeutic Enzyme Drugs Market Size Market Share by Type (2017-2028)

Figure 25. Europe Therapeutic Enzyme Drugs Market Size Market Share by Application (2017-2028)

Figure 26. Europe Therapeutic Enzyme Drugs Market Size Share by Country (2017-2028)

Figure 27. Germany Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific Therapeutic Enzyme Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific Therapeutic Enzyme Drugs Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific Therapeutic Enzyme Drugs Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific Therapeutic Enzyme Drugs Market Size Share by Region (2017-2028)

Figure 37. China Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America Therapeutic Enzyme Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America Therapeutic Enzyme Drugs Market Size Market Share by Type (2017-2028)

Figure 45. Latin America Therapeutic Enzyme Drugs Market Size Market Share by Application (2017-2028)

Figure 46. Latin America Therapeutic Enzyme Drugs Market Size Share by Country (2017-2028)

Figure 47. Mexico Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa Therapeutic Enzyme Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa Therapeutic Enzyme Drugs Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa Therapeutic Enzyme Drugs Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa Therapeutic Enzyme Drugs Market Size Share by Country (2017-2028)

Figure 53. Turkey Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE Therapeutic Enzyme Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Sanofi Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 57. BioMarin Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 58. AbbVie Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 59. Shire Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 60. Alexion Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 61. Horizon Pharma Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 62. Allergan Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 63. Johnson & Johnson Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 64. Recordati Rare Diseases Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 65. Pfizer Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 66. Vivus Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 67. Digestive Care Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2017-2022)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Therapeutic Enzyme Drugs Market Insights, Forecast to 2028

Published Date: March 2022

Report Code: QYRE-Auto-29F2881

Global Therapeutic Enzyme Drugs Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions